Blog | Association for Accessible Medicines

Bloomberg - Read the article "Why We May Lose Generic Drugs"

Apr 13, 2018 | Erik Komendant

Cotton-McCaskill PACED Act Would Help Patients Gain Access to More Affordable Generics

AAM Applauds House Passage of FDA User Fee Reauthorization

Apr 9, 2018 | Jeff Francer

AAM Has Adopted a Code of Business Ethics. Here’s What That Means.

Let's Bring Drug Prices Back to Earth

Mar 28, 2018 | Erica Klinger

Skyrocketing Drug Prices: What's Driving Up Costs?

AAM Membership Matters

Mar 1, 2018 | Jewel Smith

Why Membership Matters

Access! 2018 - Charles Cook, Jr. Addresses the Current Political and Legislative Environment

Feb 28, 2018 | Rachel Schwartz

Recap of Access! 2018 — Delivering on the Promise of Generics and Biosimilars (Part 3)

The 180-Day Rule Supports Generic Competition

Feb 27, 2018 | Erik Komendant

The 180-Day Rule Supports Generic Competition. Here’s How.

Access! 2018 - Discussion with Industry Leaders

Feb 23, 2018 | Rachel Schwartz

Recap of Access! 2018 — Chip's Call to Action (Part 2)

Keynote Address from The Honorable Eric Hargan, U.S. Department of Health and Human Services

Feb 19, 2018 | Rachel Schwartz

Recap of Access! 2018 — Successes From the Past Year (Part 1)

CBS News

Feb 2, 2018 | Kristin Murphy

Help Pass the CREATES Act

President Donald Trump - SOTU 2018

Jan 31, 2018 | Erica Klinger

Dear Mr. President

Fresenius Kabi Testimony - Ms.Ventrelli

Jan 30, 2018 | Rachel Schwartz

AAM Member Fresenius Kabi Testifies Before Congress on Drug Compounding

Anti-Competitive Evergreening Delays Patient Access

Jan 25, 2018 | Erik Komendant

Anti-Competitive Evergreening Delays Patient Access to More Affordable Generics and Biosimilars